Filoviruses: recent advances and future challenges.

about

Recent advances in research on Crimean-Congo hemorrhagic fever.Induction of caspase activation and cleavage of the viral nucleocapsid protein in different cell types during Crimean-Congo hemorrhagic fever virus infection Clinical presentation and management of severe Ebola virus disease.

P2860

Q30205763-E852A41B-4CBD-4CEA-9D03-C218257B3CBE Q34536774-B6EB1ABB-CEEB-496A-8A9E-AC5E01978551 Q38264960-1B270DCD-BB21-4CB5-8269-5D135C51425D

P2860

Filoviruses: recent advances and future challenges.

Item

http://www.wikidata.org/entity/Q44091237

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh-hant

name

Filoviruses: recent advances and future challenges.

@en

Filoviruses: recent advances and future challenges.

@nl

type

Item

label

Filoviruses: recent advances and future challenges.

@en

Filoviruses: recent advances and future challenges.

@nl

prefLabel

Filoviruses: recent advances and future challenges.

@en

Filoviruses: recent advances and future challenges.

@nl

P1476

Filoviruses: recent advances and future challenges.

@en

P2093

Mike Bray

http://www.w3.org/2001/XMLSchema#string

Richard Pilch

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple Ebola Virus Transmission Events and Rapid Decline of Central African Wildlife

Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.

Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty

Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection

Ebola virus VP40 late domains are not essential for viral replication in cell culture

Experimental therapy of filovirus infections.

Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event.

Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.

Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.

Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment.

P304

917-921

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14787210.4.6.917

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6619676

http://www.w3.org/2001/XMLSchema#string

P698

17181407

http://www.w3.org/2001/XMLSchema#string

Filoviruses: recent advances and future challenges.

about

P2860

P2860

Filoviruses: recent advances and future challenges.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698